Quantitative spectral quality assessment technique validated using intraoperative in vivo Raman spectroscopy measurements

Abstract. Significance: Ensuring spectral quality is prerequisite to Raman spectroscopy applied to surgery. This is because the inclusion of poor-quality spectra in the training phase of Raman-based pathology detection models can compromise prediction robustness and generalizability to new data. Currently, there exists no quantitative spectral quality assessment technique that can be used to either reject low-quality data points in existing Raman datasets based on spectral morphology or, perhaps more importantly, to optimize the in vivo data acquisition process to ensure minimal spectral quality standards are met. Aim: To develop a quantitative method evaluating Raman signal quality based on the variance associated with stochastic noise in important tissue bands, including C─C stretch, CH2/CH3 deformation, and the amide bands. Approach: A single-point hand-held Raman spectroscopy probe system was used to acquire 315 spectra from 44 brain cancer patients. All measurements were classified as either high or low quality based on visual assessment (qualitative) and using a quantitative quality factor (QF) metric. Receiver-operator-characteristic (ROC) analyses were performed to evaluate the performance of the quantitative metric to assess spectral quality and improve cancer detection accuracy. Results: The method can separate high- and low-quality spectra with a sensitivity of 89% and a specificity of 90% which is shown to increase cancer detection sensitivity and specificity by up to 20% and 12%, respectively. Conclusions: The QF threshold is effective in stratifying spectra in terms of spectral quality and the observed false negatives and false positives can be linked to limitations of qualitative spectral quality assessment.

[1]  Gregory W. Auner,et al.  Applications of Raman spectroscopy in cancer diagnosis , 2018, Cancer and Metastasis Reviews.

[2]  Javier Alda,et al.  Noise and Artifact Characterization of in Vivo Raman Spectroscopy Skin Measurements , 2012, Applied spectroscopy.

[3]  Edgar S. Etz,et al.  Relative Intensity Correction of Raman Spectrometers: NIST SRMs 2241 through 2243 for 785 nm, 532 nm, and 488 nm/514.5 nm Excitation , 2007, Applied spectroscopy.

[4]  Wei Zheng,et al.  In vivo, real-time, transnasal, image-guided Raman endoscopy: defining spectral properties in the nasopharynx and larynx. , 2012, Journal of biomedical optics.

[5]  L. Bernstein,et al.  Intraoperative brain cancer detection with Raman spectroscopy in humans , 2015, Science Translational Medicine.

[6]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[7]  Ming Liu,et al.  Accuracy of Raman spectroscopy in differentiating brain tumor from normal brain tissue , 2017, Oncotarget.

[8]  A. Talari,et al.  Raman Spectroscopy of Biological Tissues , 2007 .

[9]  Kevin Petrecca,et al.  Feature engineering applied to intraoperative in vivo Raman spectroscopy sheds light on molecular processes in brain cancer: a retrospective study of 65 patients. , 2019, The Analyst.

[10]  F. Saad,et al.  Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics , 2018, BJU international.

[11]  Sergio Ruiz-Moreno,et al.  Morphology-Based Automated Baseline Removal for Raman Spectra of Artistic Pigments , 2010, Applied spectroscopy.

[12]  H. Barr,et al.  Advances in the clinical application of Raman spectroscopy for cancer diagnostics. , 2013, Photodiagnosis and photodynamic therapy.

[13]  Zoya I. Volynskaya,et al.  In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. , 2006, Cancer research.

[14]  Kevin Petrecca,et al.  Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy. , 2017, Cancer research.